This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 2 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 3 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

CONTACT

http://healthconcer.blogspot.com/2014/10/contact_99.html

Diagnosis and Treatment of Colon Cancer

The colon is a part of the digestive tract that connects the stomach and small intestine to the anus.
 Colon cancer is a growth that occurs in the lining of this colon. It is an extremely common problem worldwide, with over 1 million new cases of this illness diagnosed annually. It is thought that both environmental factors such as diet and smoking, as well as genetic factors play important role in its development.

The diagnosis of colon cancer often involves colonoscopy, an examination of the colon using an instrument called colonoscope that enables an evaluation of the inner lining of the colon as well as to take a biopsy or sampling of cancer tissue.

 Once the diagnosis of colon cancer is made, the extent of the disease is often determined using a radiologic examination called CT scan. It allows an initial assessment of the extent of spread of cancer. Often routine blood tests including complete blood count (CBC), liver function tests, and a tumor marker called CEA are obtained during the initial evaluation.

There are 4 stages of colon cancer. It is defined as Stage 1, if the cancer tissue is confined to the lining of the colon or polyp. In Stage 2 colon cancer, the cancer tissue has invaded the layers of colonic wall, but has not yet spread beyond the wall. In Stage 3 colon cancer, the cancer tissue has penetrated the entire thickness of the colonic wall and spread to nearby lymph nodes. In Stage 4 disease, the cancer has spread to other organs such as liver.

The staging of colon cancer is important since the prognosis of affected individual is highly dependent on the staging of cancer.

 For example, patients diagnosed with Stage 1 colon cancer have overall 5-year survival rate of 93%. On the other hand, those diagnosed with stage 4 cancer can only expect 7% survival rate at 5 year.

For cancer that has not spread, the surgery is the treatment of choice. In fact, surgery may be the only treatment necessary for patients with Stage 1 or 2 disease.

 However, some with Stage 2 disease may elect to receive chemotherapy. Following surgery, Stage 3 cancer requires chemotherapy, usually for about 6 months.

 The most commonly used chemotherapy is called FOLFOX regimen consisting of 5-FU, leucovorin, and oxaliplatin. Some may also elect to receive additional treatment with a new class of thearpy such as Erbitux or Avastin.

 Treatment for Stage 4 disease has to be individualized as a complete cure is unlikely, although many often also receive surgery and chemotherapy.

Following these treatment, careful follow-up is recommended even when the cancer is believed to be in complete remission.

 Thus, periodic evaluations including routine blood tests including CEA, CT scan and colonoscopy are advised.

The best treatment of colon cancer is, of course, prevention.

The most effective and proven treatment option is performing colonoscopy, starting at the age of 50. All adults of this age are highly advised to undergo this life-saving procedure.
Article Source: http://EzineArticles.com/?expert=Paul_M_Choi
 

The Future of Colon Cancer Treatment

 
Future study of colorectal cancer will refine our understanding of the genetics of the disease.

This in turn will lead to earlier identification and treatment of high-risk persons.

 The future may possibly bring the use of genetic interventions to interrupt the adenoma-carcinoma sequence.
Increased awareness of colorectal cancer by the public and by private insurers, government agencies, and medical personnel will result in better use of available screening techniques.

 Development of preventive drug strategies against colorectal cancer, particularly with drugs that reduce polyp formation or prevent polyp progression to cancer, promises to be a fruitful field of endeavor.
There is ample reason to expect refinement of diagnostic and staging tests for the disease, perfection of surgical and nonsurgical techniques for treatment of large bowel cancer and its complications, and improving chemotherapeutic treatment by means of more effective and less toxic drugs.

A number of molecular markers for colorectal cancer can be measured but it is not yet clear that they have prognostic value or therapeutic implications.

 Measures of DNA synthesis or cell division are of uncertain value as clinical decision-making tools. Measurement of thymidilate synthase activity in colorectal cancer tissue is one of several markers under investigation as a prognostic indicator.

This could be useful in making decisions regarding the use of adjuvant chemotherapy for certain patients, especially those with stage II or B tumors.

 Another goal would be to collect a set of markers for cancer risk for an individual who has adenomatous polyps. Presumably, such testing could reflect exposure to colon carcinogens and help define the outlook for an individual.

 This in turn could narrow the prospective use of screening and diagnostic procedures such as colonoscopy.
Techniques to identify micrometastases in lymph node tissue are in development.

These include special stains for cytokeratin, which can identify small clusters or single malignant cells in lymph node tissue. Another method uses a technique known as PCR for detection of CEA in resected lymph nodes. PCR is a technique which permits rapid reproduction of large quantities of short segments of DNA or RNA.

Other techniques include the identification in lymph node tissue of oncogene, or tumor suppressor gene mutations, which occur in the primary tumor.

 Such techniques may be of use in reclassifying patients whose lesions are stages as II or B by conventional means and in selecting them for potentially life-saving adjuvant chemotherapy.

 Large clinical trials will be needed to determine if identification of micrometastases by these methods indeed leads to more appropriate treatment and improved progress.

Expression of the enzyme COX-2 by colorectal cancers is highly variable. Greater expressions of COX-2 by tumors are associated with lymph node metastasis, advanced stage of cancer, and poorer long-term outlook for patients.

 Thus, there could be potential future application of this test as a means of staging and prognostication.
Future study of colon cancer [http://www.105coloncancer.com] will refine our understanding of the genetics of the disease.

 This in turn will lead to earlier identification and treatment of high-risk persons.

 The future may possibly bring the use of genetic interventions to interrupt the adenoma-carcinoma sequence. For more information visit [http://www.105coloncancer.com/]
Article Source: http://EzineArticles.com/?expert=Thomas_Boggo

 

The Best Colon Cancer .

Among the most spread cancers, colon cancer usually occurs in men and women over the age of 50.
 The main causes of colon cancer are related to the patient's diet: very low in fiber and high in fat and calories.

 By keeping a healthy life style and good eating habits, you can prevent developing cancer of the colon even before this becomes a problem.

You might also want to try and check your family history for cases of colon cancer and adopt a healthier diet in order to make sure you will avoid this problem in the future.

Colon cancer treatments are varied and you can choose from a series of traditional and alternative methods of dealing with this condition.

 Surgery is often the number one choice - the surgeon removes the tumors on the colon, even if the cancer cells are spread beyond the colon itself.

This ensures less problems in the future of the patient's life, reducing chances of bowel problems or internal bleeding. Colon cancer surgery is usually categorized in four main areas: rectum resection, radio frequency ablation, colostomy and colon resection.

 The surgeon will determine which method is best suited for each individual patient.

Detecting cancer at a very early stage is important, as the problem can be corrected in a decisive and final manner.

 By using a polypectomy, the surgeon will remove suspicious polyps in order to minimize chances of the disease. Local excision may also be used in early stages, in order to remove the cancer cells.

 After surgery, your hospital should provide you with ongoing support in order to ensure a fast and efficient recovery.

Intra arterial chemotherapy is another treatment worth consideration.

 This treatment targets tumors by delivering a powerful dose of chemotherapy. Primary systemic chemotherapy is often used before a surgical procedure in order to destroy a large majority of cancer cells. Systemic therapy is usually used with metastatic cancer, while the third method, adjuvant chemotherapy, targets any cancer cells that might have been left over after surgery.

 All three chemotherapy procedures are delivered through the hepatic artery and are an option if the cancer has spread to the liver.

Another choice comes from chemoembolization treatment. In addition to being delivered intra arterially, this type of treatment blocks the blood flow to the areas affected by cancer.

 It traps the chemotherapy drugs in the area of the tumor, thus ensuring that they work efficiently and on target.

George Anderson is very interested in colon cancer and the variety of colon cancer treatments [http://www.onlycoloncancer.com/coloncancerstory/coloncancertreatment/] available.
Article Source: http://EzineArticles.com/?expert=George_Anderson